S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
[BREAKING] Pentagon to Spend Billions on "Living Missile" (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
LON:VRP

Verona Pharma plc (VRP.L) (VRP) Share Forecast, Price & News

GBX 55
+3.00 (+5.77%)
(As of 10/29/2020)
Today's Range
50
56
50-Day Range
55
55
52-Week Range
28.60
115
Volume
70,791 shs
Average Volume
150,610 shs
Market Capitalization
£228.00 million
Assets Under Management
N/A
Dividend Yield
N/A
Net Expense Ratio
0.00%
VRP stock logo

About Verona Pharma plc (VRP.L) (LON:VRP)

Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis. Verona Pharma plc was founded in 2005 and is headquartered in London, the United Kingdom.

VRP Price History

VRP ETF News Headlines

Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move
He started from nothing and became a multimillionaire...He's now one of the most sought-after trading experts...Yet he operates 858 miles from Wall Street.And now, he's revealing his #1 favorite strategy that targets MASSIVE weekly profits with just one stock ticker.
Expert Ratings for Verona Pharma
H.C. Wainwright Keeps Their Buy Rating on Verona Pharma (VRNA)
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
See More Headlines
Receive VRP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Verona Pharma plc (VRP.L) and its competitors with MarketBeat's FREE daily newsletter.

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Verona Pharma plc (VRP.L) (VRP)

Key Executives

  • Dr. Jan-Anders Karlsson (Age 64)
    CEO & Exec. Director
  • Mr. Piers John Morgan (Age 53)
    Chief Financial Officer
  • Ms. Claire Louise Poll L.C.S.W. (Age 52)
    B.A., B Juris, LLB, ASIA, Gen. Counsel
  • Ms. Victoria Stewart
    Director of Communications
  • Dr. Peter Spargo (Age 57)
    Sr. VP of Chemistry Manufacturing & Controls













VRP ETF - Frequently Asked Questions

How have VRP shares performed in 2023?

Verona Pharma plc (VRP.L)'s stock was trading at GBX 55 at the beginning of 2023. Since then, VRP stock has increased by 0.0% and is now trading at GBX 55.
View the best growth stocks for 2023 here
.

How were Verona Pharma plc (VRP.L)'s earnings last quarter?

Verona Pharma plc (VRP.L) (LON:VRP) posted its quarterly earnings results on Thursday, February, 27th. The company reported ($30.30) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($30.80) by $0.50.

What other stocks do shareholders of Verona Pharma plc (VRP.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Verona Pharma plc (VRP.L) investors own include Verona Pharma (VRNA), Fate Therapeutics (FATE), Pluristem Therapeutics (PSTI), AbbVie (ABBV), BioMarin Pharmaceutical (BMRN), Exelixis (EXEL), Amicus Therapeutics (FOLD), Global Blood Therapeutics (GBT), Grifols (GRFS) and Innoviva (INVA).

What is Verona Pharma plc (VRP.L)'s stock symbol?

Verona Pharma plc (VRP.L) trades on the London Stock Exchange (LON) under the ticker symbol "VRP."

How do I buy shares of Verona Pharma plc (VRP.L)?

Shares of VRP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Verona Pharma plc (VRP.L)'s stock price today?

One share of VRP stock can currently be purchased for approximately GBX 55.

How much money does Verona Pharma plc (VRP.L) make?

Verona Pharma plc (VRP.L) (LON:VRP) has a market capitalization of £228.00 million.

How can I contact Verona Pharma plc (VRP.L)?

Verona Pharma plc (VRP.L)'s mailing address is 3 More London Riverside, LONDON, SE1 2RE, United Kingdom. The official website for the company is www.veronapharma.com. The company can be reached via phone at +44-20-32834200.

This page (LON:VRP) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -